Navigation Links
Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting
Date:12/5/2007

NEW HAVEN, Conn., Dec. 5 /PRNewswire/ -- Connecticut's premier life science award, the CURE Award for Excellence, was presented to Alexion Pharmaceuticals, Inc. of Cheshire at the CURE annual meeting Dec 4 in New Haven.

Also presented at the meeting, to David I. Scheer of Scheer and Company of Branford, was the first-ever CURE Atlas Award for Venture Capital Achievement.

In his presentation remarks, Paul R. Pescatello, president and CEO of CURE, cited Alexion as the first Connecticut biotechnology company to have a product approved for marketing. Earlier this year Alexion launched Soliris(R), a pharmaceutical for the treatment of PNH (paroxysmal nocturnal hemoglobinuria), a rare blood disorder. Dr. Leonard Bell is CEO and David Keiser is president and COO of Alexion.

The Atlas Award was established this year to recognize venture capitalists who have made an outstanding contribution to the success of Connecticut bioscience. Pescatello said that David Scheer and his company have founded eight biotech companies since 1981, including Achillion Pharmaceuticals, Inc. and Sopherion Therapeutics, Inc. of New Haven.

Most recently Scheer helped launch Optherion, Inc. of New Haven, an early- stage biotechnology company that is developing diagnostic and disease- modifying products for the management and treatment of dry and wet age-related macular degeneration.

In other business, Pescatello noted that David Keiser of Alexion has agreed to serve as co-chair of CURE, together with Peter Farina of Boehringer Ingelheim, in the coming year. In January Farina will be assuming the duties of CEO of Developing World Cures, a newly organized subsidiary of CURE that will focus on the development of medicines for the often neglected diseases of the developing world. Kevin Rakin of Advanced BioHealing, who has been co- chair this past year, remains a director of CURE.

According to Pescatello, CURE's priorities for next year included further development of its award-winning BioBus programs, which bring laboratory science experience to Connecticut schoolchildren. The programs are poised to move from the pilot stage to full integration into Connecticut math and science education, Pescatello said.


'/>"/>
SOURCE CURE
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
2. Connecticut Bishops Back Down over Provision of Emergency Contraception
3. Connecticut Catholic Conference Wrong to Allow Plan B in Catholic Hospitals
4. CAS Medical Systems, Inc. Ranked Among Connecticuts Fastest Growing Technology Companies
5. Connecticut Girl Fights Rare Neurological Disease
6. SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations
7. Connecticut Trial Lawyers Ask Doctors to Question Insurers Excess Profits
8. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
9. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
10. Professionals in bioscience, food-related industries turn to K-State
11. Aeon Bioscience Continues Development of Drug Eluting Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: